Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1.
- DOI
- 10.1016/j.bneo.2025.100145
- Published
- 2025-07-25
- Container
- Blood Neoplasia
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bneo.2025.100145,
title = {Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1.},
author = {DiNardo CD and Jen WY and Montalban-Bravo G and Wang X and Loghavi S and Lavu S and Short NJ and Chien K and Issa GC and Pemmaraju N and Yilmaz M and Andreeff M and Borthakur G and Kadia TM and Daver NG and Garcia-Manero G and Mill CP and Su X and Fiskus W and Bhalla KN.},
year = {2025},
journal = {Blood Neoplasia},
doi = {10.1016/j.bneo.2025.100145},
url = {https://doi.org/10.1016/j.bneo.2025.100145}
}RIS
TY - JOUR TI - Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1. AU - DiNardo CD AU - Jen WY AU - Montalban-Bravo G AU - Wang X AU - Loghavi S AU - Lavu S AU - Short NJ AU - Chien K AU - Issa GC AU - Pemmaraju N AU - Yilmaz M AU - Andreeff M AU - Borthakur G AU - Kadia TM AU - Daver NG AU - Garcia-Manero G AU - Mill CP AU - Su X AU - Fiskus W AU - Bhalla KN. PY - 2025 JO - Blood Neoplasia DO - 10.1016/j.bneo.2025.100145 UR - https://doi.org/10.1016/j.bneo.2025.100145 ER -
APA
CD, D., WY, J., G, M., X, W., S, L., S, L., NJ, S., K, C., GC, I., N, P., M, Y., M, A., G, B., TM, K., NG, D., G, G., CP, M., X, S., W, F., & KN., B. (2025). Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1.. Blood Neoplasia. https://doi.org/10.1016/j.bneo.2025.100145
Source records
- europe-pmc · retrieved 2026-09-25T09:13:25.438Z